Dr. Inman on Biomarkers for Immunotherapy in Bladder Cancer
Brant Inman, MD, surgical oncologist, urologic oncologist, Duke Cancer Center discusses biomarkers for immunotherapy in patients with bladder cancer.
There are not currently good biomarkers for immunotherapy, explains Inman. However, the molecular subtypes of bladder cancer can predict response to immunotherapy.
According to Inman, these biomarkers are more telling about the biology of the tumor, rather than the response to a specific treatment.